Literature DB >> 1086863

Studies of surface immunoglobulins on human B lymphocytes. II. Characterization of a population of lymphocytes lacking surface immunoglobulins but carrying Fc receptor (SIg-Fc+ cell).

T Abo, T Yamaguchi, F Shimizu, K Kumagai.   

Abstract

Surface markers and organ distributions of B lymphocytes bearing surface immunoglobulins (SIg B) and lymphocytes lacking SIg but carrying Fc receptors (SIg-Fc+), and the variations of both the cell populations in the autoimmune diseases were studied. Peripheral blood lymphocytes contained approximately 9% SIg B and 22% SIg-Fc+ cells. Both the populations of SIg B and SIg-Fc+ cells were included in the cells that formed no E-rosettes. When previously treated with neuraminidase, however, the SIg-Fc+ cells formed E-rosettes, whereas SIg B showed no ability to form rosettes. C receptors as detected by human complement were found in the large portions of SIg B but in a minority of the SIg-Fc+ cell population. The tissues that contained the highest concentrations of SIg B and SIg-Fc+ cells were the spleen and peripheral blood, respectively. In the patients with an autoimmune disease in active stages SIg B cells in the peripheral blood markedly increased and, reversed, SIg-Fc+ cells decreased; in contrast, in remission of the diseases SIg B cells dropped down and SIg-Fc+ increased up to their normal levels. A possible relationship between the SIg B and SIg-Fc+ cells in regard to the differentiation of B lymphocytes was presemed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086863

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Antibody-dependent cellular protection against herpes simplex virus dissemination as revealed by viral plauqe and infectivity assays.

Authors:  F Shimizu; K Hanaumi; Y Shimizu; K Kumagai
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

2.  Suppression of in vitro growth of virulent and avirulent herpes simplex viruses by cell-mediated immune mechanisms, antibody, and interferon.

Authors:  F Shimizu; J Satoh; M Tada; K Kumagai
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

3.  Lymphocyte-mediated cytotoxicity in humans during revaccination with vaccinia virus.

Authors:  A Møller-Larsen; S Haahr; I Heron
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Comparison of Coulter volumes with radiometrically determined intracellular water volumes for cultured cells.

Authors:  N S Burres; C E Cass
Journal:  In Vitro Cell Dev Biol       Date:  1989-05

5.  Studies of surface immunoglobulins on human B lymphocytes. III. Physiological variations of SIg+ cells in peripheral blood.

Authors:  T Abo; K Kumagai
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

6.  DR-bearing T lymphocytes in thoracic duct lymph.

Authors:  J C Cicciarelli; P I Terasaki; Y Iwaki; R Billing; T Yamaguchi; H Takahashi; T Starzl
Journal:  Clin Immunol Immunopathol       Date:  1981-01

7.  Studies of the human lymphocyte-mouse erythrocyte bond.

Authors:  P D Zalewski; I J Forbes
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

8.  T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.

Authors:  K Okudaira; R P Searles; K Tanimoto; Y Horiuchi; R C Williams
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

9.  Treatment of multiple myeloma with deoxycoformycin.

Authors:  A R Belch; J F Henderson; L W Brox
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

10.  Studies on human blood lymphocytes with iC3b (type 3) complement receptors. II. Characterization of subsets which regulate pokeweed mitogen-induced lymphocyte proliferation and immunoglobulin synthesis.

Authors:  W Abo; J D Gray; A C Bakke; D A Horwitz
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.